- Home
- TLX vs CTRE Comparison
TLX vs CTRE Comparison
Compare TLX & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- CTRE
- Stock Information
- Founded
- TLX 2015
- CTRE 2013
- Country
- TLX Australia
- CTRE United States
- Employees
- TLX N/A
- CTRE N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- CTRE Real Estate Investment Trusts
- Sector
- TLX Health Care
- CTRE Real Estate
- Exchange
- TLX Nasdaq
- CTRE Nasdaq
- Market Cap
- TLX 5.7B
- CTRE 5.7B
- IPO Year
- TLX N/A
- CTRE N/A
- Fundamental
- Price
- TLX $15.97
- CTRE $30.73
- Analyst Decision
- TLX Strong Buy
- CTRE Buy
- Analyst Count
- TLX 3
- CTRE 7
- Target Price
- TLX $22.33
- CTRE $31.00
- AVG Volume (30 Days)
- TLX 52.5K
- CTRE 2.3M
- Earning Date
- TLX 01-01-0001
- CTRE 07-31-2025
- Dividend Yield
- TLX N/A
- CTRE 4.37%
- EPS Growth
- TLX 798.14
- CTRE 73.08
- EPS
- TLX 0.09
- CTRE 0.95
- Revenue
- TLX $484,687,790.00
- CTRE $329,837,000.00
- Revenue This Year
- TLX N/A
- CTRE $16.16
- Revenue Next Year
- TLX N/A
- CTRE $16.18
- P/E Ratio
- TLX $173.46
- CTRE $32.32
- Revenue Growth
- TLX 55.85
- CTRE 43.26
- 52 Week Low
- TLX $13.61
- CTRE $24.79
- 52 Week High
- TLX $30.36
- CTRE $33.15
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- CTRE 60.27
- Support Level
- TLX N/A
- CTRE $29.91
- Resistance Level
- TLX N/A
- CTRE $31.50
- Average True Range (ATR)
- TLX 0.00
- CTRE 0.51
- MACD
- TLX 0.00
- CTRE -0.01
- Stochastic Oscillator
- TLX 0.00
- CTRE 54.23
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.